GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Return-on-Tangible-Asset

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Return-on-Tangible-Asset : -22.61% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Malaysian Genomics Resource Centre Bhd's annualized Net Income for the quarter that ended in Mar. 2024 was RM-5.63 Mil. Malaysian Genomics Resource Centre Bhd's average total tangible assets for the quarter that ended in Mar. 2024 was RM24.91 Mil. Therefore, Malaysian Genomics Resource Centre Bhd's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -22.61%.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset or its related term are showing as below:

XKLS:0155' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -41.01   Med: -12.61   Max: 61.12
Current: -9.84

During the past 13 years, Malaysian Genomics Resource Centre Bhd's highest Return-on-Tangible-Asset was 61.12%. The lowest was -41.01%. And the median was -12.61%.

XKLS:0155's Return-on-Tangible-Asset is ranked worse than
50.86% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -9.53 vs XKLS:0155: -9.84

Malaysian Genomics Resource Centre Bhd Return-on-Tangible-Asset Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Return-on-Tangible-Asset Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 -15.18 -12.85 61.12 -20.41

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.10 -12.68 -29.56 -17.41 -22.61

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset falls into.



Malaysian Genomics Resource Centre Bhd Return-on-Tangible-Asset Calculation

Malaysian Genomics Resource Centre Bhd's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2021 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=-4.293/( (0+21.031)/ 1 )
=-4.293/21.031
=-20.41 %

Malaysian Genomics Resource Centre Bhd's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=-5.632/( (29.317+20.496)/ 2 )
=-5.632/24.9065
=-22.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Malaysian Genomics Resource Centre Bhd Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines